April 30, 2021
According to the research report titled ‘Global Beta Glucan Market 2019-2027’, available with Market Study Report LLC, global beta glucan market is projected to register a y-o-y growth rate of 7.71% through 2027.
Increasing number of consumers that are cognizant about their health as well as increasing demand for functional food are the factors augmenting the growth of global beta glucan market. Notably, beta glucan has varied application, which along with low cost of raw materials are generating industry revenues.
Request sample copy of this Report: https://www.marketstudyreport.com/request-a-sample/2487110/
However, stricter regulations on product usage acts as a restraint to worldwide beta glucan market expansion. Additionally, limited production and scarcity of molasses, coupled with high costs of extraction are major bottlenecks in the marketplace.
Based on category, global beta glucan industry is segmented into insoluble beta glucans, and soluble beta glucans. While the application rage includes food & beverage, cosmetics, and health & dietary supplements among others. According to source ambit, the marketplace is divided into cereal, bacteria, yeast, and fungus.
Moving on to regional outlook, North America, Asia-Pacific, Europe, Middle East & Africa, and Latin America are significant contributors towards worldwide beta glucan market remuneration.
The report cites that North America is poised to hold significant market share by the year 2027, owing to increased support from the government and rising investments by private players. Upsurge in prevalence of diseases like diabetes and cancer, expanding probiotic sector, along with increasing number of consumers that are health conscious are further acting as market propellers. Investments in research & development by many significant players, together with increasing acquisition & mergers are positively swaying the business dynamics in North America.
The key contenders in worldwide beta glucan market are Super Beta Glucan Inc., Kerry Group plc, Immunomedics, Ceapro Inc., Biotec Pharmacon ASA, Cargill Incorporated, Merck Millipore, Garuda International Inc., Lesaffre Human Care, Kemin Industries, Tate & Lyle plc, and Koninklijke DSM N.V.